Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy

Annals of Nuclear Medicine

Volumn 17, Issue 3, 2003, Pages 227-233

  Iguchi, Toshihiro ^a   Sato, Shuhei ^b   Kouno, Yoshihiro ^b   Okumura, Yoshihiro ^b   Akaki, Shiro ^b   Tsuda, Toshihide ^b   Kobayashi, Keita ^b   Kanazawa, Susumu ^b   Hiraki, Yoshio ^b  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

Hepatectomy; Liver fibrosis; Liver regeneration; ROC curve; Tc 99m GSA

Indexed keywords

DIAGNOSTIC AGENT; HUMAN SERUM ALBUMIN TC 99M; MACROSALB TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M DTPA GALACTOSYL HUMAN SERUM ALBUMIN; TECHNETIUM TC 99M DTPA-GALACTOSYL-HUMAN SERUM ALBUMIN;

ACCURACY; ADULT; AGED; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER REGENERATION; LIVER RESECTION; LIVER SCINTISCANNING; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; METHODOLOGY; PATHOLOGY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0038607566     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02990026     Document Type: Article

References (30)

1. Pricer WE, Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. J Biol Chem 1971; 246: 4825-4833.
2. Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 1971; 246: 1461-1467.
3. Morell AG, Irvine RA, Sternlieb I, Scheinberg IH, Ashwell G. Physical and chemical studies on ceruloplasmin. J Biol Chem 1968; 243: 155-159.
4. Miyazaki S, Takasaki K, Yamamoto M, Tsugita M, Otsubo T. Liver regeneration and restoration of liver function after partial hepatectomy: the relation of fibrosis of the liver parenchyma. Hepatogastroenterology 1999; 46: 2919-2924.
5. Ogata T, Okuda K, Ueno T, Saito N, Aoyagi S. Serum hyaluronan as a predictor of hepatic regeneration after hepatectomy in humans. Eur J Clin Invest 1999; 29: 780-785.
6. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. Ann Surg 1987; 206: 30-39.
7. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993; 18: 79-85.
8. Shimada M, Matsumata T, Adachi E, Itasaka H, Watiyama S, Sugimachi K. Estimation of degree of liver cirrhosis using a fibrosis score; a multivariate analysis of clinical parameters and resected specimens. Hepatogastroenterology 1994; 41: 177-180.
9. Kusaka K, Harihara Y, Torzilli G, Kubota K, Takayama T, Makuuchi M, et al. Objective evaluation of liver consistency to estimate hepatic fibrosis and functional reserve for hepatectomy. J Am Coll Surg 2000; 191: 47-53.
10. Gadano A, Hadengue A, Vachiery F, Moreau R, Sogni P, Soupison T, et al. Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease. J Gastroenterol Hepatol 1997; 12: 167-171.
11. Kwon A, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Use of technetium 99m diethylenetriamine-pentaacetic acidgalactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 1995; 117: 429-434.
12. Koizumi K, Uchiyama G, Arai T, Ainoda T, Yoda Y. A new liver functional study using Tc-99m DTPA-galactosyl human serum albumin: Evaluation of the validity of several functional parameters. Ann Nucl Med 1992; 6: 83-87.
13. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996; 6: 112-119.
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
15. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making 1998; 18: 110-121.
16. Kin Y, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. Doppler analysis of hepatic blood flow predicts liver dysfunction after major hepatectomy. World JSurg 1994; 18: 143-149.
17. Miyazawa K, Shimomura T, Kitamura N. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 1996; 271: 3615-3618.
18. Rigotti P, Peters JC, Tranberg K, Fischer JE. Effects of amino acid infusions on liver regeneration after partial hepatectomy in the rat. JPEN 1986; 10: 17-20.
19. Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 1994; 20: 780-787.
20. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075.
21. Burgess JB, Baenziger JU, Brown WR. Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 1992; 15: 702-706.
22. Sawamura T, Nakada H, Hazama H, Shiozaki Y, Sameshima Y, Tashiro Y. Hyperasyaloglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Gastroenterology 1984; 87: 1217-1221.
23. Sawamura T, Kawasato S, Shiozaki Y, Sameshima Y, Nakada H, Tashiro Y. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterology 1981; 81: 527-533.
24. 99mTc-GSA) liver scintigraphy. Hepatology 1997; 25: 426-429.
25. Ha-Kawa SK, Tanaka Y. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 1991; 32: 2233-2240.
26. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage. Am J Gastroenterol 1992; 87: 865-870.
27. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
28. Tomiguchi S, Kira T, Oyama Y, Nabeshima M, Nakashima R, Tsuji A, et al. Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med 1995; 20: 717-720.
29. 99mTc-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 1999; 17: 125-130.
30. 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999; 40: 1644-1651.